大麻酚
大麻素受体
大麻素
线粒体
内大麻素系统
受体
细胞生物学
化学
生物
细胞器
神经科学
大麻
生物化学
医学
精神科
兴奋剂
作者
Étienne Hébert-Chatelain
出处
期刊:Elsevier eBooks
[Elsevier]
日期:2021-01-01
卷期号:: 247-265
标识
DOI:10.1016/b978-0-12-821562-3.00047-2
摘要
Cannabis psychoactive and medicinal properties have been known for thousands of years, but it is only recently that we started to understand the cellular mechanisms triggered by phytocannabinoids, such as Δ9-tetrahydrocannabinol and cannabidiol. The discovery of the endocannabinoid system, which includes cannabinoid receptors and cannabinoids produced endogenously in animal cells, allowed a better understanding of the impact of these phytocannabinoids on human health. Early findings suggested that these molecules disrupt mitochondrial functions via direct binding to the organelle membranes and subsequent alterations of their structure and functions. The multiple tools generated after the discovery of the cannabinoid receptors in the early 1990s allowed to show that specific cannabinoids can also modulate mitochondrial activity via activation of cannabinoid receptors localized at the plasma membrane or directly within mitochondrial membranes. Considering that mitochondria are involved in the onset and progression of various diseases, it appears crucial to better understand the mechanisms linking cannabinoids and mitochondria. The aim of this chapter is to provide an overview of the multiple mechanisms triggered by cannabinoids that affects mitochondria.
科研通智能强力驱动
Strongly Powered by AbleSci AI